Dong-A Pharmaceutical Co., Ltd.

Dong-A Pharmaceutical Co., Ltd. logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1932-01-01
Employees
1K
Market Cap
-
Website
http://www.dapharm.com

Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction

Phase 3
Completed
Conditions
Interventions
First Posted Date
2013-01-24
Last Posted Date
2013-01-24
Lead Sponsor
Dong-A Pharmaceutical Co., Ltd.
Target Recruit Count
349
Registration Number
NCT01774864

Clinical Trial of Motilitone on Gastric Motor Function in Healthy Volunteers

Phase 4
Completed
Conditions
Interventions
First Posted Date
2012-11-01
Last Posted Date
2013-08-15
Lead Sponsor
Dong-A Pharmaceutical Co., Ltd.
Target Recruit Count
30
Registration Number
NCT01719575
Locations
🇰🇷

the Catholic university of korea college of Medicine, Seoul St.Mary's hospital, Banpo-dong, Seocho-gu, Seoul, Korea, Republic of

Clinical Trial Comparing the Efficacy and Safety of DA-3803 and Ovidrel

First Posted Date
2012-10-31
Last Posted Date
2013-08-13
Lead Sponsor
Dong-A Pharmaceutical Co., Ltd.
Target Recruit Count
180
Registration Number
NCT01718119
Locations
🇰🇷

Cha Medical school Gangnam-Cha hospital, Seoul, Korea, Republic of

🇰🇷

Kwandong university medical school Cheil hospital, Seoul, Korea, Republic of

🇰🇷

Cha Medical school Boondang-Cha hospital, Seongnam, Gyeong-Gi Do, Korea, Republic of

Study of SI000413 in Knee Osteoarthritis Patients

First Posted Date
2012-02-03
Last Posted Date
2013-08-13
Lead Sponsor
Dong-A Pharmaceutical Co., Ltd.
Target Recruit Count
152
Registration Number
NCT01525758
Locations
🇰🇷

Seoul National University Hospital, Seoul, Yongon-dong, Chongno-gu, Korea, Republic of

🇰🇷

KyungHee University medical center, Seoul, Hoegi-dong, Dongdaemun-gu, Korea, Republic of

🇰🇷

Ajou University Medical Center, Gyeonggi-do, Woncheon-dong Yeongtong-gu, Suwon, Korea, Republic of

Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-07-05
Last Posted Date
2013-08-13
Lead Sponsor
Dong-A Pharmaceutical Co., Ltd.
Target Recruit Count
31
Registration Number
NCT01156779
Locations
🇰🇷

Clinical Trial center, Clinical Research institute, Seoul National University Hospital, Seoul, Korea, Republic of

A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects

First Posted Date
2010-04-16
Last Posted Date
2012-07-11
Lead Sponsor
Dong-A Pharmaceutical Co., Ltd.
Target Recruit Count
106
Registration Number
NCT01104948
Locations
🇰🇷

Clinical Research Institute, Seoul National University Hospital, Seoul, Chongno-Gu, Yon-Gon Dong 28, Korea, Republic of

A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects

First Posted Date
2009-08-18
Last Posted Date
2009-08-24
Lead Sponsor
Dong-A Pharmaceutical Co., Ltd.
Target Recruit Count
110
Registration Number
NCT00961025
Locations
🇰🇷

Clinical Trials Center, Seoul National University Hospital, Seoul, Chongo-Gu, Yon-Gon Dong, Korea, Republic of

A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-08-11
Last Posted Date
2012-11-27
Lead Sponsor
Dong-A Pharmaceutical Co., Ltd.
Target Recruit Count
18
Registration Number
NCT00956306
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath